Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Samuel_Denmeade> ?p ?o. }
Showing items 1 to 51 of
51
with 100 items per page.
- Samuel_Denmeade abstract "Dr. Samuel Ray Denmeade is a Professor of Oncology, Urology and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine.As a clinical oncologist Dr. Denmeade has been the lead investigator on clinical trials testing new hormone therapies for prostate cancer. Dr. Denmeade also is a laboratory scientist focused on the development of novel ways to treat prostate cancer[citation needed]. His main research focus has been on the design and characterization of prodrugs and protoxins targeted for activation by cancer specific proteases. This research is based on the strategy that lethal drugs/toxins could be disguised as a prodrug and only released when exposed to the enzymatic activity of proteases such as PSA which are only present in its enzymatically active form in the tumor and not elsewhere in the body[citation needed]. One of these prodrugs termed G202 consists of an analog of the highly toxic natural product thapsigargin coupled to a peptide recognized as a substrate by the protease Prostate-Specific Membrane Antigen. The G202 prodrug is currently being evaluated for its toxicity and therapeutic effectiveness in clinical trials sponsored by GenSpera, Inc. Dr. Denmeade is a co-founder of GenSpera and serves as its Chief Medical Advisor. Dr. Denmeade is also one of the co-inventors of PRX302 which is a modified form of the potent bacterial toxin proaerolysin that has been reengineered for activation by the protease Prostate-Specific Antigen (PSA). PRX302 is currently under clinical development by Protox (now Sophiris), Inc. as therapy for benign prostatic hyperplasia. Dr. Denmeade was the former Chief Scientific Officer for Protox and now serves as a consultant for Sophiris. Dr. Denmeade's work has been supported by research grants from the National Cancer Institute, the Department of Defense, the Prostate Cancer Foundation and the One-in-Six Foundation. Dr. Denmeade has published over 100 papers in the area of prostate cancer research. He holds 12 US patents related to his work on cancer therapeutics.".
- Samuel_Denmeade wikiPageExternalLink denmeade.html.
- Samuel_Denmeade wikiPageID "1805398".
- Samuel_Denmeade wikiPageRevisionID "604213060".
- Samuel_Denmeade hasPhotoCollection Samuel_Denmeade.
- Samuel_Denmeade name "Denmeade, Samuel".
- Samuel_Denmeade shortDescription "American oncologist".
- Samuel_Denmeade description "American oncologist".
- Samuel_Denmeade description "American oncologist".
- Samuel_Denmeade subject Category:American_oncologists.
- Samuel_Denmeade subject Category:Johns_Hopkins_University_faculty.
- Samuel_Denmeade subject Category:Living_people.
- Samuel_Denmeade type Adult109605289.
- Samuel_Denmeade type CausalAgent100007347.
- Samuel_Denmeade type Doctor110020890.
- Samuel_Denmeade type HealthProfessional110165109.
- Samuel_Denmeade type LivingPeople.
- Samuel_Denmeade type LivingThing100004258.
- Samuel_Denmeade type MedicalPractitioner110305802.
- Samuel_Denmeade type Object100002684.
- Samuel_Denmeade type Oncologist110377633.
- Samuel_Denmeade type Oncologists.
- Samuel_Denmeade type Organism100004475.
- Samuel_Denmeade type Person100007846.
- Samuel_Denmeade type PhysicalEntity100001930.
- Samuel_Denmeade type Professional110480253.
- Samuel_Denmeade type Specialist110632576.
- Samuel_Denmeade type Whole100003553.
- Samuel_Denmeade type YagoLegalActor.
- Samuel_Denmeade type YagoLegalActorGeo.
- Samuel_Denmeade type Agent.
- Samuel_Denmeade type Person.
- Samuel_Denmeade type Person.
- Samuel_Denmeade type Q215627.
- Samuel_Denmeade type Q5.
- Samuel_Denmeade type Agent.
- Samuel_Denmeade type NaturalPerson.
- Samuel_Denmeade type Thing.
- Samuel_Denmeade type Person.
- Samuel_Denmeade comment "Dr. Samuel Ray Denmeade is a Professor of Oncology, Urology and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine.As a clinical oncologist Dr. Denmeade has been the lead investigator on clinical trials testing new hormone therapies for prostate cancer. Dr. Denmeade also is a laboratory scientist focused on the development of novel ways to treat prostate cancer[citation needed].".
- Samuel_Denmeade label "Samuel Denmeade".
- Samuel_Denmeade sameAs m.05ycx2.
- Samuel_Denmeade sameAs Q7411253.
- Samuel_Denmeade sameAs Q7411253.
- Samuel_Denmeade sameAs Samuel_Denmeade.
- Samuel_Denmeade wasDerivedFrom Samuel_Denmeade?oldid=604213060.
- Samuel_Denmeade givenName "Samuel".
- Samuel_Denmeade isPrimaryTopicOf Samuel_Denmeade.
- Samuel_Denmeade name "Denmeade, Samuel".
- Samuel_Denmeade name "Samuel Denmeade".
- Samuel_Denmeade surname "Denmeade".